SE385902B - Forfarande for extraktion av alkalisalter av deoxiribonukleinsyra ur i forveg avfettade och avproteiniserade finfordelade djurorgan - Google Patents

Forfarande for extraktion av alkalisalter av deoxiribonukleinsyra ur i forveg avfettade och avproteiniserade finfordelade djurorgan

Info

Publication number
SE385902B
SE385902B SE7113830A SE1383071A SE385902B SE 385902 B SE385902 B SE 385902B SE 7113830 A SE7113830 A SE 7113830A SE 1383071 A SE1383071 A SE 1383071A SE 385902 B SE385902 B SE 385902B
Authority
SE
Sweden
Prior art keywords
deproteinized
extraction
procedure
alkali salts
animal organs
Prior art date
Application number
SE7113830A
Other languages
English (en)
Swedish (sv)
Inventor
A Butti
G Prino
G Bertellini
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of SE385902B publication Critical patent/SE385902B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7113830A 1970-11-03 1971-10-29 Forfarande for extraktion av alkalisalter av deoxiribonukleinsyra ur i forveg avfettade och avproteiniserade finfordelade djurorgan SE385902B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT31308/70A IT1043823B (it) 1970-11-03 1970-11-03 Procedimento per l estrazione di acidi nucleici da organi animali

Publications (1)

Publication Number Publication Date
SE385902B true SE385902B (sv) 1976-07-26

Family

ID=11233430

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7113830A SE385902B (sv) 1970-11-03 1971-10-29 Forfarande for extraktion av alkalisalter av deoxiribonukleinsyra ur i forveg avfettade och avproteiniserade finfordelade djurorgan
SE7113831A SE385376B (sv) 1970-11-03 1971-10-29 Forfarande for kontrollerad, partiell nedbrytning av deoxiribonukleinsyra extraherad ur djurorgan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7113831A SE385376B (sv) 1970-11-03 1971-10-29 Forfarande for kontrollerad, partiell nedbrytning av deoxiribonukleinsyra extraherad ur djurorgan

Country Status (7)

Country Link
US (1) US3770720A (cg-RX-API-DMAC7.html)
JP (1) JPS5229320B1 (cg-RX-API-DMAC7.html)
DE (2) DE2154277A1 (cg-RX-API-DMAC7.html)
FR (2) FR2131248A5 (cg-RX-API-DMAC7.html)
GB (2) GB1366647A (cg-RX-API-DMAC7.html)
IT (1) IT1043823B (cg-RX-API-DMAC7.html)
SE (2) SE385902B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5967214A (ja) * 1982-10-12 1984-04-16 Kazuo Suga 化粧品組成物
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
IT1187833B (it) * 1985-12-12 1987-12-23 Farmigea Spa Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1212143B (it) 1987-06-26 1989-11-08 Crinos Industria Farmaco Composizione ad attivita'tricogena.
IT1222701B (it) * 1987-09-23 1990-09-12 Crinos Industria Farmaco Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
CA2299119C (en) * 1999-02-23 2013-02-05 Qiagen Gmbh A method of stabilizing and/or isolating nucleic acids
DE69928778T2 (de) 1999-06-08 2006-07-06 Gentium S.P.A., Villa Guardia Anwendung von Komplexen von kationischen Liposomen und Polydeoxyribonukleotiden wie Arzneimitteln
US6323743B1 (en) * 1999-08-24 2001-11-27 Tresness Irrevocable Patent Trust Electronic filter assembly
EP1147777A1 (en) 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
KR20070120954A (ko) * 2005-03-03 2007-12-26 젠티엄 에스피에이 신혈관 형성-의존성 종양 치료용 약학적 제제
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
WO2012063272A1 (en) 2010-11-12 2012-05-18 Gentium S.P.A. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
RU2627177C2 (ru) 2012-06-22 2017-08-03 Джентиум С.Р.Л. Способ определения биологической активности дефибротида, основанный на применении эуглобулина
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
JP2020530004A (ja) 2017-08-03 2020-10-15 ジャズ ファーマシューティカルズ アイルランド リミテッド 核酸を高濃度で含む製剤
AU2019252790A1 (en) 2018-04-12 2020-10-15 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
US20230190783A1 (en) 2020-02-28 2023-06-22 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
EP4135717A1 (en) 2020-04-17 2023-02-22 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Also Published As

Publication number Publication date
SE385376B (sv) 1976-06-28
FR2131248A5 (cg-RX-API-DMAC7.html) 1972-11-10
DE2154277C2 (cg-RX-API-DMAC7.html) 1988-04-07
JPS5229320B1 (cg-RX-API-DMAC7.html) 1977-08-01
DE2154278A1 (de) 1972-05-25
GB1366647A (en) 1974-09-11
DE2154277A1 (de) 1972-05-25
FR2131249A5 (cg-RX-API-DMAC7.html) 1972-11-10
GB1367656A (en) 1974-09-18
US3770720A (en) 1973-11-06
IT1043823B (it) 1980-02-29

Similar Documents

Publication Publication Date Title
SE385902B (sv) Forfarande for extraktion av alkalisalter av deoxiribonukleinsyra ur i forveg avfettade och avproteiniserade finfordelade djurorgan
SU430531A3 (ru) Способ получения антисептической композиции
BG17619A3 (bg) Метод за получаване на монохолии естер на 3- октадецилокси пропанол -/1/- фосфорна киселина
CH450416A (de) Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten
AR212688A1 (es) Compuestos derivados del acido 7b-amino-cefam-3-ona-4-carboxilico y procedimiento para su elaboracion
CH408006A (de) Verfahren zur Herstellung von Chinolyl-(8)-oxyessigsäurederivaten
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
IT946012B (it) Procedimento di mungitura di animali
SE396753B (sv) Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
CH520130A (de) Verfahren zur Herstellung von N-Fluordichlormethylthio-sulfamidsäure-Derivaten
SE401177B (sv) Sett att framstella nya basiskt substituerade alkylidenamino-oxialkylkarboxylsyraestrar
CH545316A (de) Verfahren zur Herstellung von Acylderivaten
BE759743A (fr) Analogues de l'acide indole acetique et leurs derives
AT309690B (de) Verfahren zur Herstellung einer verbesserten oralen Applikationsform von Raubasin
AT316498B (de) Verfahren zur Herstellung von reinen Alkalisalzen von Aminopolycarbonsäuren
AT308080B (de) Verfahren zur Herstellung von Glykolsäureestern
IT941466B (it) Procedimento per la preparazione di acidi i amminoalcan i i difo sfonici
SE381163B (sv) Anvendning av vissa fosforsyraestrar for bekempning av insekter och akarider
AT309456B (de) Verfahren zur Herstellung von trockenem Natriumdichlorisocyanurat
AT266324B (de) Verfahren zur Herstellung von festen pharmazeutischen Präparaten zur stufenweisen Abgabe von Wirkstoffen
SE393986B (sv) Sett att framstella l-(1'-cyklohexenylglycinamido)-penicillansyra
IT941467B (it) Procedimento per la preparazione di acidi i amminoalcan i i difo sfonici
FR2716M (fr) Compositions stables de sels d'esters de choline.
AT268525B (de) Verfahren zur Herstellung von neuen Derivaten der 7 Phenylacetamidocephalosporansäure
AT308746B (de) Verfahren zur Herstellung von substituierten Benzopyranen, deren Salzen, Estern und Äthern